Nurix Therapeutics, Inc. Profile Avatar - Palmy Investing

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's t…

Biotechnology
US, San Francisco [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Nurix Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Nurix Therapeutics, Inc. has no acquisition track records yet.

End of NRIX's Analysis
CIK: 1549595 CUSIP: 67080M103 ISIN: US67080M1036 LEI: - UEI: -
Secondary Listings
NRIX has no secondary listings inside our databases.